Cannasouth Limited (NZX:CBD) announces the appointment of David Petterson as a director of the following subsidiaries:
1. Cannasouth Cultivation Limited;
2. Eqalis Group New Zealand Limited;
3. Eqalis Innovations Limited;
4. Eqalis Pharmaceuticals Limited; and
5. Restoreme Clinic Limited,
and that Mark Lucas and Colin Foster are no longer directors of those companies.
The above changes are effective from 16 August 2024.
-ENDS-
For further information visit www.cannasouth.co.nz or contact:
Garry Whimp Administrator, Blacklock Rose Ltd
Email: [email protected]
Mobile: 021 587 230
Ben Francis
Administrator, Blacklock Rose Ltd
Email: [email protected]
Mobile: 021 042 6991
The S&P/NZX 50 Index closed up 0.27% or 37.19 points.
ASB flagged the class action as a contingent liability.
“ANZ NZ will continue to defend its case. Our position hasn’t changed.”
To join your company account for BusinessDesk and enjoy full access, enter your email and we’ll send you details